What Pulmonx Corporation's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 14 | 55 |
| Total trades | 14 | 66 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 3,065,000 |
| Disposed | 78,340 | 318,594 |
| Net activity | −78,340 | +2,746,406 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| French Glendon E. Iii | President and CEO | Sep 01 | Open-market sale · S | −37,784 | $2.26 | −$85.4K | 1,137,936 |
| French Glendon E. Iii | President and CEO | Sep 01 | Open-market sale · S | −4,098 | $2.26 | −$9.26K | 1,175,720 |
| Radhakrishnan Srikanth | Chief Science & Techn. Officer | Sep 01 | Open-market sale · S | −5,863 | $2.26 | −$13.3K | 316,994 |
| Radhakrishnan Srikanth | Chief Science & Techn. Officer | Sep 01 | Open-market sale · S | −3,618 | $2.26 | −$8.18K | 322,857 |
| Radhakrishnan Srikanth | Chief Science & Techn. Officer | Sep 01 | Open-market sale · S | −2,121 | $2.26 | −$4.79K | 326,475 |
| Radhakrishnan Srikanth | Chief Science & Techn. Officer | Sep 01 | Open-market sale · S | −2,643 | $2.26 | −$5.97K | 328,596 |
| Lehman David Aaron | General Counsel | Sep 01 | Open-market sale · S | −4,827 | $2.26 | −$10.9K | 361,827 |
| Lehman David Aaron | General Counsel | Sep 01 | Open-market sale · S | −3,476 | $2.26 | −$7.86K | 366,654 |
| Lehman David Aaron | General Counsel | Sep 01 | Open-market sale · S | −2,224 | $2.26 | −$5.03K | 370,130 |
| Lehman David Aaron | General Counsel | Sep 01 | Open-market sale · S | −3,807 | $2.26 | −$8.6K | 372,354 |
| Rose Geoffrey Beran | Chief Commercial Officer | Sep 01 | Open-market sale · S | −1,746 | $2.26 | −$3.95K | 449,832 |
| Rose Geoffrey Beran | Chief Commercial Officer | Sep 01 | Open-market sale · S | −1,530 | $2.26 | −$3.46K | 451,578 |
| Rose Geoffrey Beran | Chief Commercial Officer | Sep 01 | Open-market sale · S | −2,390 | $2.26 | −$5.4K | 453,108 |
| Rose Geoffrey Beran | Chief Commercial Officer | Sep 01 | Open-market sale · S | −2,213 | $2.26 | −$5K | 455,498 |
| Melenikiotou Georgia | Director | Jun 05 | Grant / award · A | +40,000 | — | — | 139,714 |
| Ferrari Richard M | Director | Jun 05 | Grant / award · A | +40,000 | — | — | 127,024 |
| Mead Dana G Jr | Director | Jun 05 | Grant / award · A | +40,000 | — | — | 139,714 |
| Florin Daniel P | Director | Jun 05 | Grant / award · A | +40,000 | — | — | 133,910 |
| Burns Thomas William | Director | Jun 05 | Grant / award · A | +40,000 | — | — | 113,399 |
| Sullivan Tiffany | Director | Jun 05 | Grant / award · A | +40,000 | — | — | 115,199 |
Loading...
